- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07349940
Tidlig opsporing af hudtumorer ved hjælp af et telemedicinsk værktøj i almen praksis (MEL)
Tidlig opdagelse af hudtumorer ved hjælp af et telemedicinsk værktøj i primærsektoren
The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic.
The primary aim of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of skin tumors by using a telemedicine tools and setting up and testing new methods and implementation into the system of social health care.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
The project is a national, prospective, multicenter, single-arm interventional pilot project for skin tumors screening involving 18 general practitioners and 6 dermatology centers in the Czech Republic.
The main objective of the project is the early detection of skin tumors by general practitioners, increasing the efficiency of healthcare, and methodically preparing, implementing, and evaluating the pilot project. The project aims to verify the suitability of the proposed early detection procedure for skin tumors, as well as to establish and test new methods and integrate them into the healthcare system.
As part of the project, the procedure will be tested on a sample of approximately 1,440 individuals, which may help validate the use of telemedicine tools in healthcare. A methodology for the use of telemedicine tools will be developed, along with a framework for collaboration between general practitioners and affiliated dermatologists. Systemic changes will be proposed to enhance the efficiency of the screening process.
The project is supported by the European Social Fund (Operational Programme Employment Plus) and the state budget of the Czech Republic. It is registered with the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0002008.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Dagmar Obšilová, Msc
- Telefonnummer: +420606429382
- E-mail: dagmar.obsilova@uzis.cz
Undersøgelse Kontakt Backup
- Navn: Lucie Mandelova, Ph.D.
- Telefonnummer: +420 770190 828
- E-mail: lucie.mandelova@uzis.cz
Studiesteder
-
-
-
Brno, Tjekkiet
- Ikke rekrutterer endnu
- St. Anne's University Hospital Brno
-
Kontakt:
- Hana Jedličková, prof.
- E-mail: hjedlic@medmuni.cz
-
Olomouc, Tjekkiet
- Rekruttering
- Olomouc University Hospital
-
Kontakt:
- Zdeněk Drlík, MD
- E-mail: zdenek.drlik@fnol.cz
-
Pilsen, Tjekkiet
- Ikke rekrutterer endnu
- University Hospital Pilsen
-
Kontakt:
- Jan Říčař, MD, Ph.D.
- E-mail: ricarj@fnplzen.cz
-
Prague, Tjekkiet
- Rekruttering
- Bulovka University Hospital
-
Kontakt:
- Filip Rob, Assoc. Prof.
- E-mail: filip.rob@bulovka.cz
-
Prague, Tjekkiet
- Ikke rekrutterer endnu
- University hospital Kralovske Vinohrady
-
Kontakt:
- Petr Arenberger, prof.
- E-mail: petr.arenberger@lf3.cuni.cz
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- at least 1 suspected lession
- phototype I or phototype II
Exclusion Criteria:
- skin lession examination by dermatologist in last 12 months
- unsigned consent to participate in the project and consent to the processing of personal data
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Adults with suspected skin lession
Pilot screening will be conducted in general practitioners' offices, where physicians will be trained to examine skin lesions using magnifying devices (dermatoscopes) and advanced telemedicine software, enabling faster diagnostics of suspicious findings. Patients with high-risk lesions will be referred to specialized dermatology centers. |
The diagnostic management of enrolled patients will be guided by standardized procedures carried out in general practitioners' offices. Physicians will be trained to identify suspicious skin lesions, capture high-resolution images using dermatoscopes, and transfer the data into advanced telemedicine software. The platform, supported by AI-driven algorithms, enables precise risk stratification of lesions and facilitates remote consultation with collaborating dermatologists. Patients with high-risk lesions will be referred to specialized dermatology centers for further examination and intervention. In cases where excision of a lesion is performed, histopathological assessment will be conducted, and results will be systematically recorded within the dedicated telemedicine platform, ensuring secure and efficient information exchange between dermatologists and general practitioners. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Potential malignancies
Tidsramme: From enrollment to the end of examination - baseline.
|
Proportion of individuals with a potential presence of malignancy (detected through the telemedicine tool). |
From enrollment to the end of examination - baseline.
|
|
Confirmed malignancies
Tidsramme: From enrollment to the end of diagnosis at 3 months.
|
Proportion of individuals with confirmed potential malignancy by a dermatologist. |
From enrollment to the end of diagnosis at 3 months.
|
|
Confirmed malignancies by histology
Tidsramme: From enrollment to the end of diagnosis at 6 months.
|
Proportion of individuals in whom the diagnosis of malignancy was confirmed histologically. |
From enrollment to the end of diagnosis at 6 months.
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studieleder: Petr Arenberger, prof., Hospital university Kralovske Vinohrady
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UZIS 2025/6
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .